Purple Biotech Ltd. Files Prospectus for $6 Million Public Offering with Potential for Additional $12 Million from Warrants
I'm PortAI, I can summarize articles.
Purple Biotech Ltd. has filed a prospectus for a public offering of 5,999,999 American Depositary Shares (ADSs) at $1.00 each, aiming to raise approximately $6 million. The offering includes short-term warrants for an additional 11,999,998 ADSs, potentially increasing proceeds by $12 million if fully exercised. The funds will support the development of oncology therapies and general corporate purposes, facilitated by H.C. Wainwright & Co. as the exclusive placement agent.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments